Congenital myasthenic syndromes in 2012.

  • Andrew Engel
  • Published 2012 in Current neurology and neuroscience reports


Congenital myasthenic syndromes (CMS) represent a heterogeneous group of disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. Clinical, electrophysiologic, and morphologic studies have paved the way for detecting CMS-related mutations in proteins residing in the nerve terminal, the synaptic… (More)
DOI: 10.1007/s11910-011-0234-7


  • Presentations referencing similar topics